MAP1A在膀胱癌组织中的表达及其与临床病理特征的关系

doi:10.11904/j.issn.1002-3070.2019.06.009

Abstract

Abstract: Objective The objective of this study was to investigate the expression of microtubule associated protein 1A(MAP1A)in bladder cancer and its correlation with clinicopathological features.Methods One hundred and thirty seven cases of bladder cancer and adjacent tissues were collected.qRT-PCR and immunohistochemistry were used to analyze the expression of MAP1A in bladder cancer and adjacent tissues.The relationship between the expression of MAP1A and clinicopathological parameters & prognosis of bladder cancer patients was studied.Results The results of qRT-PCR showed that the expression level of MAP1A in 20 cases of bladder cancer was significantly lower than that of the matched adjacent tissues(t=5.022,P＜0.001).The results of immunohistochemistry also showed that the positive expression rates of MAP1A in bladder cancer and adjacent tissues were 46.71%(46/37)and 79.56%(109/137),respectively,and the difference was statistically significant(χ²=23.52,P＜0.0001).The expression of MAP1A was closely related to clinical T stage,lymph node metastasis and TNM stage(χ²=9.982,P=0.0016;χ²=8.064,P=0.0045;χ²=7.199,P＜0.0073).Kaplan-Meier survival analysis showed that the overall survival(OS)and disease-free survival(DFS)of patients with low expression of MAP1A were significantly shorter than those with high expression of MAP1A(χ²=26.74,P＜0.0001;χ²=18.73,P＜0.0001).Cox multivariate regression analysis showed that TNM stage(HR=1.46,P=0.038)and MAP1A expression(HR=1.213,P=0.030)were independent risk factors for adverse prognosis of bladder cancer patients.Conclusion MAP1A is significantly down-regulated in bladder cancer tissues and is closely related to clinical TNM staging.The low expression of MAP1A may indicate the poor prognosis of bladder cancer patients.

Key words: Bladder cancer, Microtubule associated protein 1A, Clinicopathological features, Prognosis

CLC Number:

R694

FAN Jinhai, JIANG Yumei, ZHANG Jing, BAI Xiaojing. Expression of MAP1A in bladder cancer and its correlation with clinicopathological features[J]. Journal of Practical Oncology, 2019, 33(6): 525-530.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2019.06.009

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2019/V33/I6/525

References

1 DeSantis CE,Miller KD,Dale W,et al.Cancer statistics for adults aged 85 years and older,2019[J].CA Cancer J Clin,2019.
2 Siegel RL,Miller KD,Jemal A.Cancer statistics,2019[J].CA Cancer J Clin,2019,69(1):7-34.
3 Lotan Y,Black PC,Caba L,et al.Optimal trial design for studying urinary markers in bladder cancer:a collaborative review[J].Eur Urol Oncol,2018,1(3):223-230.
4 Humayun-Zakaria N,Arnold R,Goel A,et al.Tropomyosins:potential biomarkers for urothelial bladder cancer[J].Int J Mol Sci,2019,20(5):1102.
5 Miyamoto DT,Mouw KW,Feng FY,et al.Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer[J].Lancet Oncol,2018,19(12):683-695.
6 冯思坛.微管相关蛋白与肿瘤关系的研究进展[J].医学研究生学报,2013,26(8):878-881.
7 李建华,王润泽,李伟民.微管相关蛋白与自噬的研究进展[J].吉林医药学院学报,2018,39(4):285-290.
8 Nakayama A,Odajima T,Murakami H,et al.Characterization of two promoters that regulate alternative transcripts in the microtubule-associated protein(MAP)1A gene[J].Biochim Biophys Acta,2001,1518(3):260-266.
9 Grossman GH,Beight CD,Ebke LA,et al.Interaction of tubby-like protein-1(Tulp1)and microtubule-associated protein(MAP)1A and MAP1B in the mouse retina[J].Adv Exp Med Biol,2014,801:511-518.
10 Mohan R,John A.Microtubule-associated proteins as direct crosslinkers of actin filaments and microtubules[J].IUBMB Life,2015,67(6):395-403.
11 Perez Y,Bar-Yaacov R,Kadir R,et al.Mutations in the microtubule-associated protein MAP11(C7orf43)cause microcephaly in humans and zebrafish[J].Brain,2019,142(3):574-585.
12 Meyer MA.Highly expressed genes in human high grade gliomas:immunohistochemical analysis of data from the human protein atlas[J].Neurol Int,2014,6(2):5348.
13 Song K,Hu W,Yue F,et al.Transforming growth factor TGFβ increases levels of microtubule-associated protein MAP1S and autophagy flux in pancreatic ductal adenocarcinomas[J].PLoS One,2015,10(11):e0143150.
14 Jiang X,Zhong W,Huang H,et al.Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients[J].Mol Carcinog,2015,54(10):1194-204.
15 Knutson TP,Daniel AR,Fan D,et al.Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression[J].Breast Cancer Res,2012,14(3):95.

[1]	LIU Gengchun, SHEN Liangfang. Relationship between serum long-chain non-coding RNA MALAT1 and AFAP1-AS1,and clinicopathological features and prognosis of nasopharyngeal carcinoma [J]. Journal of Practical Oncology, 2019, 33(6): 513-518.
[2]	LIU Siwei, CUI Yue, SUN Yuanyuan, HU Jing, ZHANG Wenrui, CAO Mengru. Effect of FOXD3 in lung cancer cells [J]. Journal of Practical Oncology, 2019, 33(5): 390-396.
[3]	XIA Tianyi, ZHANG Bomiao, YAO Kefei, CUI Binbin. Clinical relationship between PTPN9 expression and colorectal cancer [J]. Journal of Practical Oncology, 2019, 33(5): 415-419.
[4]	XU Ting, YAN Feifei, ZHANG Chunhui, ZHANG Yanqiao. Analysis of clinical pathology and prognosis in patients with gastric cancer & bone metastasis [J]. Journal of Practical Oncology, 2019, 33(5): 436-441.
[5]	LI Siwei, PANG Da. Long non-coding RNA(lncRNA)role in cancer [J]. Journal of Practical Oncology, 2019, 33(5): 471-475.
[6]	QU Yanfei, LIU Chao, WANG Bojun, FANG Lin, ZHANG Yanqiao. Expression of CSN6 gene in hepatocellular carcinoma tissues and its clinical significance [J]. Journal of Practical Oncology, 2019, 33(4): 328-333.
[7]	LIU Jintao, GAO Ling, ZHOU Huiui. Expression of MAGEA4 and EB1 proteins in lung cancer tissues and their correlation with clinicopathological features and prognosis [J]. Journal of Practical Oncology, 2019, 33(4): 334-339.
[8]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[9]	FENG Yue,XING Linan,WANG Zhao,ZHANG Yunyan. Correlation between NLR and prognosis of concurrent chemoradiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 284-288.
[10]	BAI Xiaobin, HUO Longwei, XIE Wanfu, XU Gaofeng, WANG Maode. Expression of Chk1 in glioblastoma and its association with tumor biological behavior and prognosis survival [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 122-127.
[11]	SHI Xiaokang, DING Youming, WANG Bin, YU Bin, XU Yu. Expression and clinical significance of UBE2T in primary liver cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 128-133.
[12]	LU Jiaoyun, ZHANG Qingyuan. Advances in laboratory markers in the prognosis of diffuse large B-cell lymphoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 183-187.
[13]	ZHAO Fengjuan, WANG Qi, REN Yunhong, WEI Jueling, LI Lequn, ZHAO Xinhua, TANG Juan, YOU Xuemei. Changes of serum CRP and hs-CRP levels in patients with liver cancer and depression and their influence on prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 27-33.
[14]	ZHANG Fengchun, JIANG Ying, LIU Zhaonan, YAN Ningning, CUI Hongquan, XU Yingchun. Prognostic significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in systemic inflammation-related indicators in gastric cancer patients after radical resection [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 34-39.
[15]	MA Jianli, ZHANG Minghui, JI Hongfei, XU Xiangying. Clinical significance of combined detection of PD-L1 protein and CD8⁺TILs in resected lung adenocarcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 40-46.

Expression of MAP1A in bladder cancer and its correlation with clinicopathological features

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments